M. DeRosa

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Ovarian Cancer, Version 2.2020

Malley, D. Matei, A. Berchuck, 2021 .

PND26 VALIDATING USE OF THE MIGRAINE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE VERSION 2.1 (MSQ) ACROSS MIGRAINE DISORDERS

R. Rendas-Baum, S. Varon, Min Yang, 2010 .

Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

P. Sabbatini, E. Ratner, L. Havrilesky, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Supplemental online content for : NCCN Guidelines ® Insights : Ovarian Cancer , Version 1 . 2019

D. Matei, A. Berchuck, J. Berek, 2019 .

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.

D. Matei, A. Berchuck, M. Dwyer, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

D. Matei, A. Berchuck, E. Ratner, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Representations Concerning Long-Term Use of Benzodiazepines Hypnotics, by Patients Over 65, Treated in General Practice. A Qualitative Study Using Individual Interviews

P. Llorca, N. Authier, C. Dibao-Dina, 2016 .

NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.

D. Matei, A. Berchuck, J. Berek, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.